Document ID: chunk:federal_register_of_legislation:F2025L00063:schedule:1
Version: federal_register_of_legislation:F2025L00063
Segment Type: schedule
Provision Reference: sch 1
Character Range: 2181–2964

Schedule 1—Amendments

National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

     1.            Schedule 1, omit entry for Alirocumab
     2.            Schedule 1, after entry for Estradiol in the form Transdermal patches 390 micrograms, 8
insert:
   Transdermal patches 390 micrograms, 24 (S19A)  20  1  1

     1.            Schedule 1, entry for Niraparib
    omit:
   Capsule 100 mg (as tosilate monohydrate)  20  56  2
                                             20  56  5
                                             20  84  2
                                             20  84  5

     1.            Schedule 1, after entry for Selegiline
         insert:
Selpercatinib  Capsule 40 mg  20  56   5
               Capsule 80 mg  20  112  5